JP2018108937A5 - - Google Patents

Download PDF

Info

Publication number
JP2018108937A5
JP2018108937A5 JP2016221064A JP2016221064A JP2018108937A5 JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5 JP 2016221064 A JP2016221064 A JP 2016221064A JP 2016221064 A JP2016221064 A JP 2016221064A JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5
Authority
JP
Japan
Prior art keywords
optionally substituted
hydrogen
substituted alkyl
optionally
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016221064A
Other languages
English (en)
Japanese (ja)
Other versions
JP6978758B2 (ja
JP2018108937A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016221064A priority Critical patent/JP6978758B2/ja
Priority claimed from JP2016221064A external-priority patent/JP6978758B2/ja
Priority to US15/809,845 priority patent/US10392400B2/en
Publication of JP2018108937A publication Critical patent/JP2018108937A/ja
Priority to US16/459,120 priority patent/US10844073B2/en
Publication of JP2018108937A5 publication Critical patent/JP2018108937A5/ja
Application granted granted Critical
Publication of JP6978758B2 publication Critical patent/JP6978758B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016221064A 2016-11-11 2016-11-11 パラジウム媒介ケトール化 Expired - Fee Related JP6978758B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化
US15/809,845 US10392400B2 (en) 2016-11-11 2017-11-10 Palladium-mediated ketolization
US16/459,120 US10844073B2 (en) 2016-11-11 2019-07-01 Palladium-mediated ketolization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Publications (3)

Publication Number Publication Date
JP2018108937A JP2018108937A (ja) 2018-07-12
JP2018108937A5 true JP2018108937A5 (cg-RX-API-DMAC10.html) 2019-12-26
JP6978758B2 JP6978758B2 (ja) 2021-12-08

Family

ID=62240368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016221064A Expired - Fee Related JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Country Status (2)

Country Link
US (2) US10392400B2 (cg-RX-API-DMAC10.html)
JP (1) JP6978758B2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SI3606928T1 (sl) 2017-04-05 2023-02-28 President And Fellows Of Harvard College Makrociklična spojina in njene uporabe
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CA2632433C (en) 1998-06-17 2012-02-07 Eisai R & D Management Co., Ltd. Methods for preparing macrocyclic analogs and intermediates for preparing same
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
JP2001305734A (ja) * 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
KR101434673B1 (ko) 2004-06-03 2014-08-26 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 b 유사체의 제조를 위한 중간체
JP2008522623A (ja) 2004-12-09 2008-07-03 エーザイ株式会社 ハリコンドリンbアナログを使用した癌治療でのチューブリンアイソタイプのスクリーニング
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CN201230323Y (zh) 2007-03-07 2009-04-29 美商内数位科技公司 用于产生和处理媒介接入控制协议数据单元的节点b
CN101918844A (zh) 2007-06-18 2010-12-15 米迪缪尼有限公司 表达epha2和erbb2的细胞的协同治疗
EP2578576B9 (en) 2007-10-03 2016-09-14 Eisai R&D Management Co., Ltd. Intermediates for the synthesis of halichondrin B analogs
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
RU2517167C2 (ru) 2008-04-04 2014-05-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Аналоги галихондрина в
US8203010B2 (en) 2010-01-26 2012-06-19 Eisai R&D Management Co., Ltd. Compounds useful in the synthesis of halichondrin B analogs
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2015501818A (ja) 2011-12-16 2015-01-19 アルフォラ リサーチ インコーポレイテッドAlphora Research Inc. 3−((2s,5s)−4−メチレン−5−(3−オキソプロピル)テトラヒドロフラン−2−イル)プロパノール誘導体およびそれらの有用な中間体を調製する方法
IN2014MN01521A (cg-RX-API-DMAC10.html) 2011-12-29 2015-05-01 Alphora Res Inc
CN104334562A (zh) 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
WO2015000070A1 (en) 2013-07-03 2015-01-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CA2929084C (en) 2013-11-04 2022-01-11 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin b
BR112016012237B1 (pt) 2013-12-06 2023-02-07 Eisai R&D Management Co., Ltd Métodos úteis na síntese de análogos de halicondrina b
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
SI3606928T1 (sl) 2017-04-05 2023-02-28 President And Fellows Of Harvard College Makrociklična spojina in njene uporabe
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis

Similar Documents

Publication Publication Date Title
EA021854B1 (ru) Дисахариновая, дифумаровокислая, ди-1-гидрокси-2-нафтойнокислая и монобензойнокислая соли 4-(диметиламино)бутил-2-(4-((2-амино-4-метил-6-(пентиламино)пиримидин-5-ил)метил)фенил)ацетата
CN104402862B (zh) 艾立替尼的制备方法
WO2016012470A1 (en) New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
AU2007225678A1 (en) Quinolone derivative or pharmaceutically acceptable salt thereof
JP2017522276A5 (cg-RX-API-DMAC10.html)
CA2722016A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
ES2594252T3 (es) Compuesto de quinolona y composición farmacéutica
JP2010529986A5 (cg-RX-API-DMAC10.html)
JPH06234741A (ja) 置換4−フエニルピリドン及び4−フエニル−2−アルコキシピリジン
CN105418610A (zh) 一种10-羟基吴茱萸碱类抗肿瘤化合物及其制备方法和应用
EP4149510A1 (en) Novel intermediates and synthesis for endochin-like quinolone compounds
WO2013018371A1 (ja) ビアリールエステル誘導体、及びそれを含む医薬
CN115175913B (zh) 取代的双三环化合物及其药物组合物和用途
JP2008542359A5 (cg-RX-API-DMAC10.html)
Le Anh et al. Synthesis and Molecular Structure of Dibenzo [4-(α-Thienyl-and α-Pyrrolyl) pyrido] aza-14-crown-4 Ethers
CN101544670A (zh) 一种糖精阿德福韦酯及制备方法
JP3839813B2 (ja) カンプトテシン誘導体の調製に有用な化合物
JP2018505184A5 (cg-RX-API-DMAC10.html)
CN115135646B (zh) 取代的多环化合物及其药物组合物和用途
JP2020533308A5 (cg-RX-API-DMAC10.html)
Luo et al. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol
JP2010513510A5 (cg-RX-API-DMAC10.html)
TWI439463B (zh) 青蒿素之二聚衍生物及其在抗癌治療之應用
Diwischek et al. Cerulenin analogues as inhibitors of efflux pumps in drug‐resistant Candida albicans
CN105121419B (zh) Cabazitaxel类抗多药耐药紫杉烷类抗肿瘤化合物及其制备方法